InterCure Ltd.
INCR
$1.60
$0.053.23%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -99.55% | -74.95% | -37.03% | 102.74% | 863.13% |
| Total Depreciation and Amortization | -74.05% | -33.64% | -0.26% | 36.48% | 50.49% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,049.39% | -167.00% | -85.12% | -118.28% | -101.74% |
| Change in Net Operating Assets | -886.92% | 87.60% | -32.07% | -99.99% | -267.86% |
| Cash from Operations | -198.46% | -147.65% | -113.10% | -109.16% | 61.62% |
| Capital Expenditure | 96.71% | 77.88% | 56.65% | 30.47% | -35.22% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 67.69% | 89.63% | -27.66% | 30.67% | 37.09% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 92.12% | 5.76% | -46.77% | -283.85% | -249.91% |
| Cash from Investing | 90.24% | 30.91% | -20.07% | -98.64% | -105.96% |
| Total Debt Issued | -96.28% | -47.76% | -1.85% | 157.75% | 249.17% |
| Total Debt Repaid | 48.28% | -32.27% | -70.87% | -1,428.00% | -1,205.75% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 77.40% | 41.76% | -274.40% | -252.28% | -256.67% |
| Cash from Financing | -147.46% | -122.50% | -92.71% | -80.26% | -41.75% |
| Foreign Exchange rate Adjustments | -98.75% | -121.52% | -138.25% | 282.23% | 252.02% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -428.59% | -1,620.52% | -614.80% | -156.00% | -77.53% |